Article ; Online: Cardioprotective effects of fucoidan against hypoxia-induced apoptosis in H9c2 cardiomyoblast cells.
2015 Volume 53, Issue 9, Page(s) 1352–1357
Abstract: Context: Cardiomyocyte apoptosis plays a critical role in the progress of heart diseases. Fucoidan, a complex-sulfated polysaccharide, has been reported to possess potential cardioprotective efficacy in vivo.: Objective: The present study determines ... ...
Abstract | Context: Cardiomyocyte apoptosis plays a critical role in the progress of heart diseases. Fucoidan, a complex-sulfated polysaccharide, has been reported to possess potential cardioprotective efficacy in vivo. Objective: The present study determines whether fucoidan could provide cardioprotection on hypoxia-induced cardiomyocyte apoptosis. Materials and methods: H9c2 cardiomyoblast cells were incubated with various concentrations (15, 30, and 60 μg/ml) of fucoidan in a humidified incubator at 37 °C with 95% O2 and 5% CO2. After 6 h, hypoxia was processed and the cardioprotective effects of fucoidan were evaluated by applying MTT, ELISA, Hoechst 33258 nucleus staining, and western blot. Results: Following a 6 h exposure of H9c2 to hypoxic condition, significant reduction was found in cell survival (0.57-fold) and superoxide dismutase (SOD) activity (0.56-fold), which were associated with the increase of malondialdehyde (MDA) level (2.58-fold), creatine phosphokinase (CK, 3.57-fold), and lactate dehydrogenase (LDH) activities (2.39-fold). Moreover, hypoxia-induced apoptosis was confirmed by Hoechst 33258 nuclear staining, and these changes were accompanied by the increase of Bcl-2 (1.27-fold) and Bax expression (2.6-fold). However, preincubation of the cells with fucoidan prior to hypoxia exposure elevated the cell viability (30 μg/ml, 1.18-fold; 60 μg/ml, 1.32-fold) and SOD activity (30 μg/ml, 1.12-fold; 60 μg/ml, 1.25-fold), but decreased the MDA level (30 μg/ml, 0.70-fold; 60 μg/ml, 0.80-fold), CK (30 μg/ml, 0.69-fold; 60 μg/ml, 0.76-fold), and LDH (30 μg/ml, 0.67-fold; 60 μg/ml, 0.86-fold) leakages. Hoechst 33258 nuclear staining observations demonstrated the same protective effect of fucoidan on hypoxia-induced myocardial injury. Also, cardioprotective effects of fucoidan were reflected by increasing Bcl-2 (60 μg/ml, 1.84-fold), as well as decreasing Bax (60 μg/ml, 0.6-fold). Conclusion: Fucoidan had protective effect against hypoxia-induced cardiomyocytes apoptosis, and the mechanism might involve protections of the cell from oxidative injury. |
---|---|
MeSH term(s) | Animals ; Antioxidants/pharmacology ; Apoptosis/drug effects ; Biomarkers/metabolism ; Cell Hypoxia ; Cell Line ; Cell Survival/drug effects ; Creatine Kinase/metabolism ; Cytoprotection ; Dose-Response Relationship, Drug ; L-Lactate Dehydrogenase/metabolism ; Malondialdehyde/metabolism ; Myoblasts, Cardiac/drug effects ; Myoblasts, Cardiac/metabolism ; Myoblasts, Cardiac/pathology ; Polysaccharides/pharmacology ; Proto-Oncogene Proteins c-bcl-2/metabolism ; Rats ; Superoxide Dismutase/metabolism ; Time Factors ; bcl-2-Associated X Protein/metabolism |
Chemical Substances | Antioxidants ; Bax protein, rat ; Biomarkers ; Polysaccharides ; Proto-Oncogene Proteins c-bcl-2 ; bcl-2-Associated X Protein ; Malondialdehyde (4Y8F71G49Q) ; fucoidan (9072-19-9) ; L-Lactate Dehydrogenase (EC 1.1.1.27) ; Superoxide Dismutase (EC 1.15.1.1) ; Creatine Kinase (EC 2.7.3.2) |
Language | English |
Publishing date | 2015 |
Publishing country | England |
Document type | Journal Article |
ZDB-ID | 1440131-9 |
ISSN | 1744-5116 ; 1388-0209 |
ISSN (online) | 1744-5116 |
ISSN | 1388-0209 |
DOI | 10.3109/13880209.2014.982298 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.B 1300: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.